But remember: Repurchases don't always pay off for investors.
The Affordable Care Act implies a major reform in the public and private health insurance industry, which should increase demand for drugs and diagnostic equipment.
Despite large first-quarter gains, 2 big Dow stocks show strong monthly chart formations and are worthy of new buying.
The generics drugmaker plans to tackle AstraZeneca's blockbuster antipsychotic drug Seroquel next.
Global food giant Nestle looks good.
In the current climate, a good defense can be your best offense.
This monthly scan is helpful for identifying which stocks may be too risky for new buying. It also turns up a pair of compelling 'buy' candidates.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.